前往化源商城

No to hattatsu. Brain and development 2013-09-01

[Epileptic encephalopathy associated with forced normalization after administration of levetiracetam].

Takahiro Kikuchi, Mitsuhiro Kato, Nobuya Takahashi, Kazuyuki Nakamura, Kiyoshi Hayasaka

文献索引:No To Hattatsu. 45(5) , 375-8, (2013)

全文:HTML全文

摘要

Here we report a case of a 10-year-old female with unclassified epileptic encephalopathy who showed forced normalization after administration of levetiracetam (LEV). She initially presented with intractable tonic and myoclonic seizures that were observed about 10 times a day along with frequent multifocal sharp and slow wave complexes on electroencephalography (EEG). We were forced to decrease the topiramate dose because of the appearance of nystagmus, and her myoclonic seizures became worse. We added LEV (250 mg/day) and her tonic and myoclonic seizures disappeared one day after initiation of LEV administration. However, she showed hyporesponsiveness and akinesia. The disappearance of paroxysmal discharges on EEG confirmed the diagnosis of forced normalization. Despite continuous administration of LEV, tonic and myoclonic seizures relapsed within a month but her psychotic symptoms resolved simultaneously. To the best of our knowledge, this is the first reported case of forced normalization after LEV administration. It should be noted that LEV may cause forced normalization although it can be started at an adequate dosage.

相关化合物

结构式 名称/CAS号 全部文献
吡拉西坦 结构式 吡拉西坦
CAS:7491-74-9
乙拉西坦 结构式 乙拉西坦
CAS:33996-58-6
(R)-左乙拉西坦 结构式 (R)-左乙拉西坦
CAS:103765-01-1
左乙拉西坦 结构式 左乙拉西坦
CAS:102767-28-2